Opportunities to rehabilitation of multimorbid patients with asthma and obesity
Lyudmila V. Tribuntseva , Andrey V. Budnevsky , Galina G. Prozorova , Oleg N. Choporov , Irina A. Olysheva , Yaroslava M. Savvina
Russian Family Doctor ›› 2024, Vol. 28 ›› Issue (3) : 46 -57.
Opportunities to rehabilitation of multimorbid patients with asthma and obesity
BACKGROUND: The challenges of rehabilitation and achieving asthma control in patients with multimorbid conditions remain relevant despite advances in asthma treatment. Improving therapeutic approaches requires not only the development of new drugs, but also the creation of comprehensive individualized rehabilitation programs.
AIM: To develop complex rehabilitation programs for patients with asthma and multimorbid diseases (obesity, osteoarthritis) and assess their impact on asthma and comorbid conditions.
MATERIALS AND METHODS: 70 patients with asthma and obesity were divided into two groups: a rehabilitation group and a control group. The study evaluated external respiration functions, quality of life using Asthma Quality of Life Questionnaire (standardized), asthma control with Asthma Control Questionnaire-5 (ACQ-5), multimorbid pathology with Cumulative Illness Rating Scale (CIRS), Lequesne index, exercise capacity via 6-minute walk test, physical activity using questionnaire ODA23+, and levels of interleukin-6, interleukin-4, tumor necrosis factor alpha, leptin.
RESULTS: Both groups were comparable across all assessed parameters, with most participants presenting moderate to severe asthma. Physical activity levels were low to moderate. The CIRS index was 10.0 ± 1.1 in group 1 and 9.2 ± 1.1 in group 2 (p > 0.05), while the Lequesne index was 9.70 ± 1.47 and 8.80 ± 1 (p = 0.3900), respectively. After rehabilitation program, the Lequesne index in the group 1 decreased by 2.37 ± 0.60 (р < 0,05), which correlated with improved exercise tolerance (6-minute walk test) and increased physical activity by 6.57 ± 2.00 (р < 0.05), and increased asthma control (with ACQ-5 decreasing by 0.74 ± 0.20 points; р < 0.05) and quality of life with Asthma Quality of Life Questionnaire (standardized) 3.8 ± 0.4 to 4.5 ± 0.3 (р < 0.05). In group 2, no significant changes were observed in the Lequesne index, physical activity, asthma control, or quality of life (p > 0.05). Proinflammatory cytokines, including interleukin-6, tumor necrosis factor alpha, and leptin, decreased significantly in group 1, while the control group showed no significant changes.
CONCLUSIONS: Multicomponent rehabilitation programs tailored to the individual characteristics of patients with multimorbid conditions contribute to better management of both asthma and comorbidities. Rehabilitation improves asthma control, quality of life, and exercise tolerance. It also helps to reduce pain syndrome, increase physical activity, and decrease proinflammatory cytokines and leptin levels.
asthma / obesity / multimorbidity / quality of life / osteoarthritis / rehabilitation
| [1] |
Drapkina OM, Avdeev SN, Budnevsky AV, et al. Multimorbidity in asthma. Russian Journal of Preventive Medicine. 2024;27(1):84–89. EDN: WGCNXU doi: 10.17116/profmed20242701184 |
| [2] |
Драпкина О.М., Авдеев С.Н., Будневский А.В., и др. Мультиморбидность при бронхиальной астме // Профилактическая медицина. 2024. Т. 27, № 1. С. 84–89. EDN: WGCNXU doi: 10.17116/profmed20242701184 |
| [3] |
Koo HK, Song P, Lee JH. Novel association between asthma and osteoarthritis: a nationwide health and nutrition examination survey. BMC Pulm Med. 2021;21:59. doi: 10.1186/s12890-021-01425-6 |
| [4] |
Koo H.K., Song P., Lee J.H. Novel association between asthma and osteoarthritis: a nationwide health and nutrition examination survey // BMC Pulm Med. 2021. Vol. 21. P. 59. doi: 10.1186/s12890-021-01425-6 |
| [5] |
Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12:580–592. doi: 10.1038/nrrheum.2016.136 |
| [6] |
Robinson W.H., Lepus C.M., Wang Q., et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis // Nat Rev Rheumatol. 2016. Vol. 12. P. 580–592. doi: 10.1038/nrrheum.2016.136 |
| [7] |
Baker MC, Sheth K, Lu R, et al. Increased risk of osteoarthritis in patients with atopic disease. Ann Rheum Dis. 2023;82(6):866–872. doi: 10.1136/ard-2022-223640 |
| [8] |
Baker M.C., Sheth K., Lu R., et al. Increased risk of osteoarthritis in patients with atopic disease // Ann Rheum Dis. 2023. Vol. 82, N 6. P. 866–872. doi: 10.1136/ard-2022-223640 |
| [9] |
Wang Q, Lepus CM, Raghu H, et al. IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis. Elife. 2019;8:e39905. doi: 10.7554/eLife.39905 |
| [10] |
Wang Q., Lepus C.M., Raghu H., et al. IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis // Elife. 2019. Vol. 8. P. e39905. doi: 10.7554/eLife.39905 |
| [11] |
Pelaia C, Heffler E, Crimi C, et al. Interleukins 4 and 13 in asthma: key pathophysiologic cytokines and drug gable molecular targets. Front Pharmacol. 2022;13:851940. doi: 10.3389/fphar.2022.851940 |
| [12] |
Pelaia C., Heffler E., Crimi C., et al. Interleukins 4 and 13 in asthma: key pathophysiologic cytokines and druggable molecular targets // Front Pharmacol. 2022. Vol. 13. P. 851940. doi: 10.3389/fphar.2022.851940 |
| [13] |
Li D, Xie G, Wang W. Reactive oxygen species: the 2-edged sword of osteoarthritis. Am J Med Sci. 2012;344(6):486–490. doi: 10.1097/MAJ.0b013e3182579dc6 |
| [14] |
Li D., Xie G., Wang W. Reactive oxygen species: the 2-edged sword of osteoarthritis // Am J Med Sci. 2012. Vol. 344, N 6. P. 486–490. doi: 10.1097/MAJ.0b013e3182579dc6 |
| [15] |
Henrotin Y, Kurz B, Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage. 2005;13(8):643–654. doi: 10.1016/j.joca.200504.002 |
| [16] |
Henrotin Y., Kurz B., Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes? // Osteoarthritis Cartilage. 2005. Vol. 13, N 8. P. 643–654. doi: 10.1016/j.joca.200504.002 |
| [17] |
Michaeloudes C, Abubakar-Waziri H, Lakhdar R, et al. Molecular mechanisms of oxidative stress in asthma. Mol Aspects Med. 2022;85:101026. doi: 10.1016/j.mam.2021.101026 |
| [18] |
Michaeloudes C., Abubakar-Waziri H., Lakhdar R., et al. Molecular mechanisms of oxidative stress in asthma // Mol Aspects Med. 2022. Vol. 85. P. 101026. doi: 10.1016/j.mam.2021.101026 |
| [19] |
Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574–584. doi: 10.1016/S2213-2600(16)30048-0 |
| [20] |
Peters M.C., McGrath K.W., Hawkins G.A., et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts // Lancet Respir Med. 2016. Vol. 4, N 7. P. 574–584. doi: 10.1016/S2213-2600(16)30048-0 |
| [21] |
Kaneko S, Satoh T, Chiba J, et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther. 2000;6(2):71–79. doi: 10.1080/13684730050515796 |
| [22] |
Kaneko S., Satoh T., Chiba J., et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis // Cytokines Cell Mol Ther. 2000. Vol. 6, N 2. P. 71–79. doi: 10.1080/13684730050515796 |
| [23] |
Budnevsky AV, Tribuntseva LV, Chernik TA, et al. Impact of osteoarthritis on the asthma clinical course: focus on physical activity and quality of life. Therapy. 2024;10(2):7–13. EDN: TRIUXZ doi: 10.18565/therapy.2024.2.7-13 |
| [24] |
Будневский А.В., Трибунцева Л.В., Черник Т.А., и др. Влияние остеоартрита на течение бронхиальной астмы: фокус на физическую активность и качество жизни // Терапия. 2024. Т. 10, № 2. С. 7–13. EDN: TRIUXZ doi: 10.18565/therapy.2024.2.7-13 |
| [25] |
Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the idea randomized clinical trial. JAMA. 2013;310(12):1263–1273. doi: 10.1001/jama.2013.277669 |
| [26] |
Messier S.P., Mihalko S.L., Legault C., et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the idea randomized clinical trial // JAMA. 2013. Vol. 310, N 12. P. 1263–1273. doi: 10.1001/jama.2013.277669 |
| [27] |
Henriksen M, Klokker L, Graven-Nielsen T, et al. Association of exercise therapy and reduction of pain sensitivity in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Care Res. 2014;66:1836–1843. doi: 10.1002/acr.22375 |
| [28] |
Henriksen M., Klokker L., Graven-Nielsen T., et al. Association of exercise therapy and reduction of pain sensitivity in patients with knee osteoarthritis: a randomized controlled trial // Arthritis Care Res. 2014. Vol. 66. P. 1836–1843. doi: 10.1002/acr.22375 |
| [29] |
Global Strategy for Asthma Management and Prevention [Internet]. Available from: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf |
| [30] |
Global Strategy for Asthma Management and Prevention [Электронный ресурс]. Режим доступа: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf |
| [31] |
Urroz Guerrero PD, Oliveira JM, Lewthwaite H, et al. Considerations when addressing physical inactivity and sedentary behaviour in people with asthma. J Clin Med. 2023;12(18):5998. doi: 10.3390/jcm12185998 |
| [32] |
Urroz Guerrero P.D., Oliveira J.M., Lewthwaite H., et al. Considerations when addressing physical inactivity and sedentary behaviour in people with asthma // J Clin Med. 2023. Vol. 12, N 18. P. 5998. doi: 10.3390/jcm12185998 |
| [33] |
Sadek Attalla S, Ow NL, McNarry M, De Simoni A. Experiences of exercise in patients with asthma: a qualitative analysis of discussions in a UK asthma online community. BJGP Open. 2022;6(3):BJGPO.2021.0162. doi: 10.3399/BJGPO.2021.0162 |
| [34] |
Sadek Attalla S., Ow N.L., McNarry M., De Simoni A. Experiences of exercise in patients with asthma: a qualitative analysis of discussions in a UK asthma online community // BJGP Open. 2022. Vol. 6, N 3. P. BJGPO.2021.0162. doi: 10.3399/BJGPO.2021.0162 |
| [35] |
Dedov II, Mokrysheva NG, Mel’nichenko GA, et al. Obesity. Clinical guidelines. Consilium Medicum. 2021;23(4):311–325. EDN: GYUVLJ doi: 10.26442/20751753.2021.4.200832 |
| [36] |
Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А., и др. Ожирение. Клинические рекомендации // Consilium Medicum. 2021. Т. 23, № 4. С. 311–325. EDN: GYUVLJ doi: 10.26442/20751753.2021.4.200832 |
| [37] |
Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115(5):1265–1270. doi: 10.1378/chest.115.5.1265 |
| [38] |
Juniper E.F., Buist A.S., Cox F.M., et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire // Chest. 1999. Vol. 115, N 5. P. 1265–1270. doi: 10.1378/chest.115.5.1265 |
| [39] |
Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–907. doi: 10.1034/j.1399-3003.1999.14d29.x |
| [40] |
Juniper E.F., O’Byrne P.M., Guyatt G.H., et al. Development and validation of a questionnaire to measure asthma control // Eur Respir J. 1999. Vol. 14. P. 902–907. doi: 10.1034/j.1399-3003.1999.14d29.x |
| [41] |
Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;(16)5:622–626. doi: 10.1111/j.1532-5415.1968.tb02103.x |
| [42] |
Linn B.S., Linn M.W., Gurel L. Cumulative illness rating scale // J Am Geriatr Soc. 1968. Vol. 16, N 5. P. 622–626. doi: 10.1111/j.1532-5415.1968.tb02103.x |
| [43] |
Bubnova MG, Aronov DM, Boytsov SA. Methodic recommendations maintaining physical activity of those with limitations in health. CardioSomatics. 2016;7(1):5–50. EDN: VXCWTH doi: 10.26442/CS45189 |
| [44] |
Бубнова М.Г., Аронов Д.М., Бойцов С.А. Методические рекомендации Обеспечение физической активности граждан, имеющих ограничения в состоянии здоровья // CardioСоматика. 2016. Т. 7, № 1. C. 5–50. EDN: VXCWTH doi: 10.26442/CS45189 |
| [45] |
Tribuntceva LV, Budnevsky AV, Prozorova GG, et al. The role of extrapulmonary personalized factors in asthma control. Sechenov Medical Journal. 2023;14(1):27–38. EDN: AJNNPB doi: 10.47093/2218-7332.2023.14.1.27-38 |
| [46] |
Трибунцева Л.В., Будневский А.В., Прозорова Г.Г., и др. Оценка влияния внелегочных персонифицированных факторов на контроль бронхиальной астмы // Сеченовский вестник. 2023. Т. 14, № 1. С. 27–38. EDN: AJNNPB doi: 10.47093/2218-7332.2023.14.1.27-38 |
| [47] |
Tribuntseva LV, Avdeyev SN, Budnevskiy AV, et al. Combined effect of multimorbidity and increased body mass index on control of bronchial asthma and quality of patients’ life. I.P. Pavlov Russian Medical Biological Herald. 2023;31(1):37–48. EDN: EEVMAY doi: 10.17816/PAVLOVJ111895 |
| [48] |
Трибунцева Л.В., Авдеев С.Н., Будневский А.В., и др. Сочетанное влияние мультиморбидности и повышенного индекса массы тела на контроль бронхиальной астмы и качество жизни пациентов // Российский медико-биологический вестник имени академика И.П. Павлова. 2023. Т. 31, № 1. С. 37–48. EDN: EEVMAY doi: 10.17816/PAVLOVJ111895 |
| [49] |
Tribuntceva LV, Budnevsky AV, Prozorova GG, et al. Quality of life of patients with asthma: the effects of overweight, obesity and multi morbidity. Russian Family Doctor. 2024;28(2):51–60. EDN: ROLRJO doi: 10.17816/RFD627462 |
| [50] |
Трибунцева Л.В., Будневский А.В., Прозорова Г.Г., и др. Качество жизни пациентов с бронхиальной астмой: влияние избыточной массы тела, ожирения и мультиморбидности // Российский семейный врач. 2024. Т. 28, № 2. С. 51–60. EDN: ROLRJO doi: 10.17816/RFD627462 |
| [51] |
Achkasov EE, Talambum EA, Horol’skaya AB, et al. Physical therapy for respiratory diseases. Moscow: Triada-Х; 2011. 100 p. (In Russ.) |
| [52] |
Ачкасов Е.Е., Таламбум Е.А., Хорольская А.Б., и др. Лечебная физическая культура при заболеваниях органов дыхания. Москва: Триада-Х, 2011. 100 с. |
| [53] |
Freitas PD, Ferreira PG, Silva AG, et al. The role of exercise in a weight-loss program on clinical control in obese adults with asthma. A randomized controlled trial. Am J Respir Crit Care Med. 2017;195(1):32–42. doi: 10.1164/rccm.201603-0446OC |
| [54] |
Freitas P.D., Ferreira P.G., Silva A.G., et al. The role of exercise in a weight-loss program on clinical control in obese adults with asthma. A randomized controlled trial // Am J Respir Crit Care Med. 2017. Vol. 195, N 1. P. 32–42. doi: 10.1164/rccm.201603-0446OC |
| [55] |
Moseng T, Vliet Vlieland TPM, Battista S, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 2024;83(6):730–740. doi: 10.1136/ard-2023-225041 |
| [56] |
Moseng T., Vliet Vlieland T.P.M., Battista S., et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update // Ann Rheum Dis. 2024. Vol. 83, N 6. P. 730–740. doi: 10.1136/ard-2023-225041 |
| [57] |
Song JA, Oh JW. Effects of aquatic exercises for patients with osteoarthritis: systematic review with meta-analysis. Healthcare (Basel). 2022;10(3):560. doi: 10.3390/healthcare10030560 |
| [58] |
Song J.A., Oh J.W. Effects of aquatic exercises for patients with osteoarthritis: systematic review with meta-analysis // Healthcare (Basel). 2022. Vol. 10, N 3. P. 560. doi: 10.3390/healthcare10030560 |
| [59] |
Hinman RS, Heywood SE, Day AR. Aquatic physical therapy for hip and knee osteoarthritis: results of a single-blind randomized controlled trial. Phys Ther. 2007;87(1):32–43. doi: 10.2522/ptj.20060006 |
| [60] |
Hinman R.S., Heywood S.E., Day A.R. Aquatic physical therapy for hip and knee osteoarthritis: results of a single-blind randomized controlled trial // Phys Ther. 2007. Vol. 87, N 1. P. 32–43. doi: 10.2522/ptj.20060006 |
| [61] |
Tribuntceva LV, Budnevsky AV, Prozorova GG, et al. Cytokine profile and markers of fat metabolism in patients with asthma, obesity and multimorbidity. Russian family doctor. 2023;27(3):31–42. EDN: MLDYPJ doi: 10.17816/RFD424986 |
| [62] |
Трибунцева Л.В., Будневский А.В., Прозорова Г.Г., и др. Цитокиновый профиль и маркеры жирового обмена у пациентов с бронхиальной астмой, ожирением и мультиморбидностью // Российский семейный врач. 2023. Т. 27, № 3. С. 31–42. EDN: MLDYPJ doi: 10.17816/RFD424986 |
| [63] |
Bantulà M, Roca-Ferrer J, Arismendi E, Picado C. Asthma and obesity: two diseases on the rise and bridged by inflammation. J Clin Med. 2021;10:169. doi: 10.3390/jcm10020169 |
| [64] |
Bantulà M., Roca-Ferrer J., Arismendi E., Picado C. Asthma and obesity: two diseases on the rise and bridged by inflammation // J Clin Med. 2021. Vol. 10. P. 169. doi: 10.3390/jcm10020169 |
| [65] |
Jiang L, Tian W, Wang Y, et al. Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine. 2012;79(3):291–297. doi: 10.1016/j.jbspin.2011.05.015 |
| [66] |
Jiang L., Tian W., Wang Y., et al. Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysis // Joint Bone Spine. 2012. Vol. 79, N 3. P. 291–297. doi: 10.1016/j.jbspin.2011.05.015 |
| [67] |
Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911–919; quiz 920. doi: 10.1016/j.jaci.2005.02.023 |
| [68] |
Fantuzzi G. Adipose tissue, adipokines, and inflammation // J Allergy Clin Immunol. 2005. Vol. 115, N 5. P. 911–919; quiz 920. doi: 10.1016/j.jaci.2005.02.023 |
| [69] |
Aguiar GC, Do Nascimento MR, De Miranda AS, et al. Effects of an exercise therapy protocol on inflammatory markers, perception of pain, and physical performance in individuals with knee osteoarthritis. Rheumatol Int. 2015;35(3):525–531. doi: 10.1007/s00296-014-3148-2 |
| [70] |
Aguiar G.C., Do Nascimento M.R., De Miranda A.S., et al. Effects of an exercise therapy protocol on inflammatory markers, perception of pain, and physical performance in individuals with knee osteoarthritis // Rheumatol Int. 2015. Vol. 35, N 3. P. 525–531. doi: 10.1007/s00296-014-3148-2 |
| [71] |
Komlosi Z, van de Veen W, Kovacs N, et al. Cellular and molecular mechanisms of allergic asthma. Mol Aspects Med. 2022;85:100995. doi: 10.1016/j.mam.2021.100995 |
| [72] |
Komlosi Z., van de Veen W., Kovacs N., et al. Cellular and molecular mechanisms of allergic asthma // Mol Aspects Med. 2022. Vol. 85. P. 100995. doi: 10.1016/j.mam.2021.100995 |
Eco-Vector
/
| 〈 |
|
〉 |